Indication
Peanut allergy
Peanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*). Read more about Peanut allergy
14 drugs 1 manufacturers
Drugs that treat it
Common Peanut allergy therapies.
PALFORZIA (LEVEL 1) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 2) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 3) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 4) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 5) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 6) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 7) (peanut allergen powder-dnfp)
PALFORZIA (LEVEL 8) (peanut allergen powder-dnfp)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPeanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*).
Primarily affecting children but often persisting lifelong into adulthood, it engages the immune system and multiple organ systems, including the cutaneous, gastrointestinal, respiratory, and cardiovascular tracts.
Exposure leads to rapid cross-linking of allergen-specific IgE on mast cells and basophils, resulting in systemic release of inflammatory mediators.
Clinically, reactions range from acute urticaria, angioedema, pruritus, and vomiting to severe, potentially fatal respiratory compromise, vascular collapse, and systemic anaphylaxis.
- nih.gov
Peanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*) Exposure leads to rapid cross-linking of allergen-specific IgE on mast cells and basophils, resulting in systemic release of inflammatory mediators Clinically, reactions range from acute urticaria, angioedema, pruritus, and vomiting to severe, potentially fatal respiratory compromise, vascular collapse, and systemic anaphylaxis
- aaaai.org
Peanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*)
- nih.gov
Primarily affecting children but often persisting lifelong into adulthood, it engages the immune system and multiple organ systems, including the cutaneous, gastrointestinal, respiratory, and cardiovascular tracts Clinically, reactions range from acute urticaria, angioedema, pruritus, and vomiting to severe, potentially fatal respiratory compromise, vascular collapse, and systemic anaphylaxis
- nih.gov
Primarily affecting children but often persisting lifelong into adulthood, it engages the immune system and multiple organ systems, including the cutaneous, gastrointestinal, respiratory, and cardiovascular tracts
- acaai.org
Primarily affecting children but often persisting lifelong into adulthood, it engages the immune system and multiple organ systems, including the cutaneous, gastrointestinal, respiratory, and cardiovascular tracts Clinically, reactions range from acute urticaria, angioedema, pruritus, and vomiting to severe, potentially fatal respiratory compromise, vascular collapse, and systemic anaphylaxis
- aaaai.org
Exposure leads to rapid cross-linking of allergen-specific IgE on mast cells and basophils, resulting in systemic release of inflammatory mediators
Personalize your experience
Follow Peanut allergy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.